Back to Search
Start Over
Second line immune checkpoint inhibition in urothelial cancer
- Publication Year :
- 2019
-
Abstract
- Urothelial cancer (UC) is devastating disease, once it reaches muscle invasive (MIBC) and metastatic stage. Even when performing radical cystectomy (RC) with pelvic lymphadenectomy in patients with MIBC, approximately half of the patients will develop metastasis and still no long-term cure for metastatic urothelial cancer (mUC) has been found (1).
- Subjects :
- Oncology
medicine.medical_specialty
business.industry
Urology
medicine.medical_treatment
Muscle invasive
Disease
medicine.disease
Immune checkpoint
Metastasis
Cystectomy
03 medical and health sciences
0302 clinical medicine
Second line
Reproductive Medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Urothelial cancer
030212 general & internal medicine
Stage (cooking)
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....04d4d46a9b5f2938b9c131c725a0b024